Commitment COM-264
Post-approval commitment for NMPA-2021-0064. Category: Pharmacovigilance. Priority: medium.
Commitment ID
COM-264
Application
Authority
National Medical Products Administration
Category
Pharmacovigilance
Priority
medium
Status
Overdue
Due Date
2025-12-06
Completed At
—
Owner
Aisha Okonkwo
Created
2023-07-31
Description
Provide confirmatory bioequivalence study for 200 mg strength
Evidence (0)
No evidence documents attached. Upload evidence to mark this commitment as complete.